Related Experiment Videos
Abstract:
Antibiotics with small but definable mortality, such as chloramphenicol, should not be used when safer drugs will suffice. Antibiotics with a low (1 to 5 per cent) morbidity should not be used when safer drugs are available. Therefore, cleocin, minocycline, or oral erythromycin estolate should rarely be used and regular erythromycin base is almost always preferable. Fever should not be treated with antibiotics since they are not antipyretics. "Colds" should not be treated with antibiotics, but antibiotics should be administered to patients with a history of chronic bronchitis, sinusitis, and recurrent otitis as soon as any symptoms begin. Intramuscular antibiotics should not be given except for benzathine penicillin. Use placebos instead of antibiotics when the patient's psyche demands an intramuscular injection. Make certain that the needle, syringe, and solution are sterile. Agents other than penicillin or cephalosporins should be used in patients with a definite history of penicillin allergy. Combination antibiotics or broad spectrum antibiotics like cephelosporins or tetracyclines should not be used when narrow spectrum antibiotics of known efficacy are available for specific syndromes such as streptococcal pharyngitis.
Insights
Avoid using antibiotics with mortality risks like chloramphenicol when safer options exist. Reserve antibiotics for specific conditions, not fevers or colds, and prefer narrow-spectrum drugs.
Area of Science:
- Pharmacology
- Infectious Disease Management
Background:
- Antibiotic selection involves balancing efficacy with potential risks like mortality and morbidity.
- Certain antibiotics, such as chloramphenicol, carry definable mortality risks.
- Some antibiotics, like cleocin, minocycline, and oral erythromycin estolate, present low but significant morbidity rates.
Purpose of the Study:
- To provide guidelines for judicious antibiotic use in clinical practice.
- To emphasize the importance of selecting safer and more appropriate antibiotic agents.
- To differentiate between appropriate and inappropriate indications for antibiotic therapy.
Main Methods:
- Review of existing literature and clinical guidelines on antibiotic usage.
- Analysis of antibiotic-associated mortality and morbidity data.
- Formulation of recommendations based on drug safety profiles and specific clinical syndromes.
Main Results:
- Antibiotics with mortality risks (e.g., chloramphenicol) should be avoided if safer alternatives are available.
- Antibiotics with low morbidity (1-5%) should be reserved for situations where no safer drugs exist.
- Specific antibiotics like cleocin, minocycline, and oral erythromycin estolate should be used sparingly, with erythromycin base often preferred.
- Antibiotics are ineffective for fever and the common cold; however, they are indicated for acute symptom onset in chronic bronchitis, sinusitis, and recurrent otitis.
- Intramuscular antibiotic administration should be limited to benzathine penicillin; placebos can be used for psychological benefit.
- Alternative antibiotics to penicillin or cephalosporins are recommended for patients with a history of penicillin allergy.
- Broad-spectrum or combination antibiotics (e.g., cephalosporins, tetracyclines) should not be used when narrow-spectrum agents are effective for specific infections like streptococcal pharyngitis.
Conclusions:
- Judicious antibiotic selection is crucial to minimize patient harm and prevent resistance.
- Prioritize antibiotics with lower risk profiles and proven efficacy for specific indications.
- Avoid antibiotic use for non-bacterial conditions like fever and the common cold.